Healthcare News and Headlines
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Healthcare Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HealthcareNewsCBO: Medicaid Spending Increases Will Slow Due To OBBBA But Expected To Continue
CBO: Medicaid Spending Increases Will Slow Due To OBBBA But Expected To Continue
HealthcareInsurance

CBO: Medicaid Spending Increases Will Slow Due To OBBBA But Expected To Continue

•February 12, 2026
0
Inside Health Policy
Inside Health Policy•Feb 12, 2026

Why It Matters

Policymakers must balance budgetary cuts with the reality of escalating health costs for remaining beneficiaries, influencing future Medicaid reform debates.

Key Takeaways

  • •OBBBA cuts $1.2 trillion from Medicaid over ten years
  • •Spending growth will decelerate but remain positive
  • •Remaining enrollees projected to have higher health costs
  • •State budgets may face tighter Medicaid funding constraints
  • •Long‑term fiscal pressure could spur further reform discussions

Pulse Analysis

The Omnibus Budget Reconciliation Act, enacted as part of last year’s reconciliation package, represents the most aggressive federal effort in decades to curb Medicaid expenditures. By targeting eligibility thresholds and reimbursement rates, the legislation is projected to shave $1.2 trillion from the program’s ten‑year outlay, a figure that dwarfs typical annual adjustments. While the cut is substantial, the CBO emphasizes that it does not reverse the underlying demographic trends driving Medicaid demand. As the baby‑boomer cohort ages and chronic disease prevalence climbs, the pool of beneficiaries who remain enrolled will require increasingly costly services, from hospitalizations to long‑term care.

Even with the OBBBA‑induced slowdown, Medicaid’s growth path stays positive because of three converging forces. First, medical inflation consistently outpaces general price growth, especially for specialty drugs and high‑intensity procedures. Second, state Medicaid expansions and eligibility extensions, encouraged by recent federal incentives, continue to broaden the enrollee base. Third, the health status of retained beneficiaries is deteriorating; as healthier individuals lose coverage, the average cost per enrollee rises. These factors combine to offset the fiscal headwinds introduced by the budget bill, ensuring that total spending will still climb, albeit at a reduced rate.

For state governments and health insurers, the CBO’s outlook signals a need to reassess budgeting and care‑management strategies. Tightened federal allocations may force states to prioritize cost‑containment measures such as value‑based payment models, increased use of telehealth, and stricter utilization reviews. At the same time, the projected rise in per‑capita costs could pressure legislators to revisit Medicaid expansion decisions or explore supplemental funding mechanisms. Ultimately, the interplay between fiscal restraint and rising health needs will shape the next wave of Medicaid policy, making it a focal point for both budget officers and health‑care executives.

CBO: Medicaid Spending Increases Will Slow Due To OBBBA But Expected To Continue

CBO: Medicaid Spending Increases Will Slow Due To OBBBA But Expected To Continue | InsideHealthPolicy.com

Jump to Navigation

--

--

Friday, February 13, 2026

--

CBO: Medicaid Spending Increases Will Slow Due To OBBBA But Expected To Continue

  • [Tweet]

Last year’s reconciliation bill will cut about $1.2 trillion in Medicaid spending over the next decade, but overall Medicaid spending is still expected to increase as the beneficiaries who retain coverage are expected to become sicker, the Congressional Budget Office (CBO) says.


--

Log in to access this content.

Username *

Password *

Remember me

--

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

--

FEATURES

  • [Insider]

  • [Documents]

  • The Vitals--

  • [Daily News]

NEWSLETTERS

  • [Inside TeleHealth]

  • [Inside Drug Pricing]

  • [Health Exchange Alert]

  • [Inside CMS]

  • [FDA Week]

TOPICS

  • [21st Century Cures]

  • [Waste and Fraud]

  • [User Fees]

  • [Tobacco]

  • [The Courts]

  • [Spotlight on ACOs]

  • [Rx Drugs]

  • [Opioids]

  • [Medicare]

  • [Medical Devices]

  • [Medicaid]

  • [Food Safety]

  • [Emergency Response]

  • [Cybersecurity]

  • [Congress]

  • [Budget]

  • [Health Reform Debate]

  • [Health Equity]

  • [Abortion]

  • [Coronavirus]

  • [Post-Chevron]

ABOUT US

  • [Home]

  • [About Inside Washington Publishers]

  • [Advertising on Inside Health Policy]

  • [Privacy Policy]

  • [Terms and Conditions]

  • [About Inside Health Policy]

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or [[email protected]].

STAY CONNECTED

--

© 2002-2026. Inside Washington Publishers | [Contact Us]

--

Read Original Article
0

Comments

Want to join the conversation?

Loading comments...